BioStock: Pricing in focus for Respiratorius ahead of partnering discussions
Oncology company Respiratorius are now working on marketing VAL001 with the aim of securing a partnership. A new formulation and the possibility of differentiation from already available products is considered the single most important component to ensure attractive pricing for an upcoming market launch. In this article, BioStock looks at the company’s own pricing analysis and the market potential that it believes the project possesses.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se